Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EDAPNASDAQ:PETVNASDAQ:TELANASDAQ:VANI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEDAPEDAP TMS$1.70-0.6%$1.82$1.26▼$5.46$63.94M0.0198,079 shs15,349 shsPETVPetVivo$0.70$0.67$0.29▼$0.98$16.99M0.8720,327 shs15,573 shsTELATELA Bio$1.67+11.3%$1.26$0.86▼$5.56$59.33M0.78231,130 shs148,171 shsVANIVivani Medical$1.15$1.09$0.91▼$1.50$68.13M2.9397,405 shs33,502 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEDAPEDAP TMS-1.22%-5.03%-8.60%-25.44%-67.86%PETVPetVivo0.00%+0.91%0.00%+32.08%+27.27%TELATELA Bio+11.33%-10.70%+45.22%-28.63%-67.13%VANIVivani Medical0.00%-3.36%+7.48%+4.55%-13.53%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEDAPEDAP TMS1.8841 of 5 stars3.23.00.00.00.61.70.6PETVPetVivoN/AN/AN/AN/AN/AN/AN/AN/ATELATELA Bio2.182 of 5 stars3.43.00.00.01.01.70.6VANIVivani Medical2.1388 of 5 stars3.53.00.00.00.03.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEDAPEDAP TMS 2.33Hold$8.50400.00% UpsidePETVPetVivo 0.00N/AN/AN/ATELATELA Bio 2.75Moderate Buy$7.25334.13% UpsideVANIVivani Medical 3.00Buy$4.00247.83% UpsideCurrent Analyst Ratings BreakdownLatest PETV, VANI, EDAP, and TELA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2025VANIVivani MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$4.00 ➝ $4.005/15/2025EDAPEDAP TMSPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral4/16/2025VANIVivani MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$4.00 ➝ $4.004/4/2025EDAPEDAP TMSJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold$8.00 ➝ $2.004/4/2025VANIVivani MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$4.00 ➝ $4.003/28/2025EDAPEDAP TMSPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$5.00 ➝ $4.503/28/2025EDAPEDAP TMSHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$19.00 ➝ $19.003/26/2025VANIVivani MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$4.00 ➝ $4.003/21/2025TELATELA BioCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$12.00 ➝ $7.003/21/2025TELATELA BioPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral$5.00 ➝ $2.00(Data available from 6/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEDAPEDAP TMS$69.18M0.92N/AN/A$1.18 per share1.44PETVPetVivo$1.05M16.24N/AN/A($0.03) per share-23.33TELATELA Bio$69.30M0.95N/AN/A$0.72 per share2.32VANIVivani MedicalN/AN/AN/AN/A$0.30 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEDAPEDAP TMS-$20.58M-$0.62N/AN/AN/A-34.45%-51.42%-26.43%8/27/2025 (Estimated)PETVPetVivo-$10.95M-$0.45N/A∞N/A-902.82%-4,813.07%-281.78%6/26/2025 (Estimated)TELATELA Bio-$37.84M-$1.41N/AN/AN/A-61.00%-402.45%-62.73%8/11/2025 (Estimated)VANIVivani Medical-$23.49M-$0.43N/AN/AN/AN/A-133.07%-56.50%8/12/2025 (Estimated)Latest PETV, VANI, EDAP, and TELA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025EDAPEDAP TMS-$0.16-$0.20-$0.04-$0.20$16.56 million$16.37 million5/13/2025Q1 2025VANIVivani Medical-$0.10-$0.11-$0.01-$0.11N/AN/A5/8/2025Q1 2025TELATELA Bio-$0.21-$0.25-$0.04-$0.25$17.35 million$18.52 million3/31/2025Q4 2024VANIVivani Medical-$0.10-$0.11-$0.01-$0.11N/AN/A3/27/2025Q4 2024EDAPEDAP TMS-$0.11-$0.05+$0.06-$0.05$20.83 million$22.69 million3/20/2025Q4 2024TELATELA Bio-$0.24-$0.23+$0.01-$0.23$23.17 million$17.65 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEDAPEDAP TMSN/AN/AN/AN/AN/APETVPetVivoN/AN/AN/AN/AN/ATELATELA BioN/AN/AN/AN/AN/AVANIVivani MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEDAPEDAP TMS0.101.741.21PETVPetVivo0.020.420.47TELATELA Bio2.284.223.40VANIVivani MedicalN/A2.402.40Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEDAPEDAP TMS62.74%PETVPetVivo24.55%TELATELA Bio94.35%VANIVivani Medical6.78%Insider OwnershipCompanyInsider OwnershipEDAPEDAP TMS0.23%PETVPetVivo10.84%TELATELA Bio4.70%VANIVivani Medical46.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEDAPEDAP TMS23037.39 million37.31 millionOptionablePETVPetVivo2024.27 million19.06 millionNot OptionableTELATELA Bio12039.56 million37.70 millionOptionableVANIVivani Medical2059.24 million31.76 millionOptionablePETV, VANI, EDAP, and TELA HeadlinesRecent News About These CompaniesVivani Medical Appoints Anthony Baldor as Chief Financial OfficerJune 11, 2025 | manilatimes.netVivani Medical to Present at the 2025 BIO International ConventionJune 11, 2025 | finance.yahoo.comVivani Stock Gains After Announcing Spin-Off Plans for Cortigent UnitJune 2, 2025 | zacks.comCompanies To Watch: Vivani MedicalMay 30, 2025 | lifescienceleader.comVivani files with SEC to spin off neurostim business, focus on drug delivery implantsMay 29, 2025 | massdevice.comVivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani ShareholdersMay 29, 2025 | finance.yahoo.comHC Wainwright Estimates Vivani Medical Q1 EarningsMay 24, 2025 | marketbeat.comVivani Medical (NASDAQ:VANI) Receives Buy Rating from HC WainwrightMay 21, 2025 | marketbeat.comVivani Medical Reports Q1 2025 Results and Strategic UpdatesMay 20, 2025 | tipranks.comVivani Medical, Inc.: Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial ResultsMay 15, 2025 | finanznachrichten.deVivani Medical, Inc. Reports Successful Initial Data from LIBERATE-1™ Study and Secures $3M in Equity FinancingMay 13, 2025 | quiverquant.comVivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial ResultsMay 13, 2025 | globenewswire.comVivani Medical CEO to Present on Innovative Drug Delivery Solutions at AAPS Virtual WorkshopMay 9, 2025 | nasdaq.comVivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual WorkshopMay 7, 2025 | globenewswire.comVivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & CompanyApril 16, 2025 | finance.yahoo.comVivani Medical, Okava expand collaboration to develop OKV-119 for dogsApril 16, 2025 | markets.businessinsider.comVivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and LongevityApril 15, 2025 | globenewswire.comGregg Williams Purchases 18,529 Shares of Vivani Medical, Inc. (NASDAQ:VANI) StockApril 12, 2025 | insidertrades.comVivani Medical, Inc. (NASDAQ:VANI) Director Purchases $33,660.00 in StockApril 9, 2025 | insidertrades.comWeight loss implants to increase compliance and cut admin burden for patientsApril 3, 2025 | finance.yahoo.comVivani Medical Reports 2024 Financial Results and Business ProgressApril 1, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePETV, VANI, EDAP, and TELA Company DescriptionsEDAP TMS NASDAQ:EDAP$1.70 -0.01 (-0.58%) As of 06/18/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.PetVivo NASDAQ:PETV$0.70 0.00 (0.00%) As of 06/18/2025 03:34 PM EasternPetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.TELA Bio NASDAQ:TELA$1.66 +0.17 (+11.00%) As of 06/18/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.Vivani Medical NASDAQ:VANI$1.15 0.00 (0.00%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$1.15 0.00 (0.00%) As of 06/18/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Chime’s Smart IPO: Half the Valuation, Double the Strength Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Tesla Bulls and Bears Collide: What Investors Should Know Qualcomm: A Technical Setup Is Emerging, and It's Bullish 330% Returns YTD: Is CoreWeave's Momentum Softening? Why Quantum Computing Inc. Is the Quiet Winner in Quantum Stocks 3 Catalysts in 7 Days: Archer's Growth Story Just Accelerated Microsoft-OpenAI Rift May Cap Stock Upside Potential Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
